Exelixis, Inc.
USD48.54
-1.74 (-3.46%)
CEO
Michael Morrissey
IPO Date
2000-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$50.34
Prev. Close
$50.28
Day Low
$48.41
Day High
$50.44
52W Low
$33.76
52W High
$52.96
Market Cap
$12.20B
Volume
2.48M
| 8,367 |
| $0.00 |
| 29 May 2026 | Eckhardt Sue Gail | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Smith Julie | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Freire Maria C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Beckerle Mary C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Oliver Bob | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | WYSZOMIERSKI JACK L | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | POSTE GEORGE | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | JOHNSON DAVID EDWARD | director | A-Award | Acquired | 19,133 | $50.03 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Partial) | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |